June 8, 2009 (FinancialWire) — XOMA Ltd. (NASDAQ: XOMA), a leader in the discovery and development of antibody therapeutics, announced that Steven Engle, chairman and chief executive officer of XOMA, is scheduled to present at the 8th Annual Needham Life Sciences Conference. The presentation will take place in New York City on Wednesday, June 10, at 10: 00 a.m. eastern time.

An audio webcast of the presentation will be available live at www.wsw.com/webcast/needham31/xoma/ or via the Investors tab at the XOMA website, www.xoma.com. An archived version of the webcast will be available for 90 days following the presentation.

XOMA discovers, develops and manufactures therapeutic antibodies designed to treat inflammatory, autoimmune, infectious and oncological diseases.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.